SEARCH

SEARCH BY CITATION

References

  • 1
    Levy M. Hepatorenal syndrome. Kidney Int 1993; 43:737753.MEDLINE
  • 2
    Schrier RW, Niederberger M, Weigert A, Ginès P. Peripheral arterial vasodilation: determinant of functional spectrum of cirrhosis. Semin Liver Dis 1994; 14:1422.MEDLINE
  • 3
    Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996; 23:164173.MEDLINE
  • 4
    Epstein M. Hepatorenal syndrome. In: EpsteinM, ed. The Kidney in Liver Disease. 4th ed. Philadelphia: Hanley & Belfus, 1996:75108.
  • 5
    Bataller R, Ginès P, Guevara M, Arroyo V. Hepatorenal syndrome. Semin Liver Dis 1997; 17:233248.MEDLINE
  • 6
    Gonwa TA, Klintmalm GB, Levy M, Jennings LS, Goldstein RM, Husberg BS. Impact of pretransplant renal function on survival after liver transplantation. Transplantation 1995; 59:361365.MEDLINE
  • 7
    Laffi G, La Villa G, Gentilini P. Pathogenesis and management of the hepatorenal syndrome. Semin Liver Dis 1994; 14:7181.MEDLINE
  • 8
    Rössle M, Haag K, Ochs A, Sellinger M, Nöldge G, Perarnau JM, Berger E, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994; 330:165171.MEDLINE
  • 9
    Shiffman ML, Jeffers L, Hoofnagle JH, Tralka TL. The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: a conference sponsored by the National Digestive Disease Advisory Board. Hepatology 1995; 25:15911597.
  • 10
    Ring EJ, Lake JR, Roberts JP, Gordon RL, LaBerge JM, Read AE, Sterneck MR, et al. Using transjugular intrahepatic portosystemic shunt to control variceal bleeding before liver transplantation. Ann Intern Med 1992; 116:304309.MEDLINE
  • 11
    Cabrera J, Maynar M, Granados R, Gorriz E, Reyes R, Pulido-Duque JM, Sanroman JLR, et al. Transjugular intrahepatic portosystemic shunt (TIPS) vs. esclerotherapy in the elective treatment of variceal haemorrhage. Gastroenterology 1996; 110:832839.MEDLINE
  • 12
    Jalan R, Forrest EH, Stanley AJ, Redhead DN, Forbes J, Dillon JF, MacGilchrist AJ, et al. A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology 1997; 26:11151122.MEDLINE
  • 13
    Grace ND. TIPS: the search for a proper role. In: ArroyoV, BoschJ, BrugueraM, RodésJ, eds. Therapy in Liver Disease. The Pathophysiological Basis of Therapy. Barcelona: Masson S.A., 1997:435440.
  • 14
    Grace ND. TIPS: the long and short of it. Gastroenterology 1997; 112:10401043.MEDLINE
  • 15
    Ferral H, Bjarnason H, Wegryn SA, Rengel GJ, Nazarian GK, Rank JM, Tadavarthy SM, et al. Refractory ascites: early experience in treatment with transjugular intrahepatic portosystemic shunt. Radiology 1993; 189:795801.MEDLINE
  • 16
    Somberg KA, Lake JR, Tomlanovich SJ, Laberge JM, Feldstein V, Bass NM. Transjugular intrahepatic portosystemic shunt for refractory ascites: Assessment of clinical and humoral response and renal function. Hepatology 1995; 21:709716.MEDLINE
  • 17
    Quiroga J, Sangro B, Nuñez M, Bilbao I, Longo J, García-Villarreal L, et al. Transjugular intrahepatic portal-systemic shunt in the management of refractory ascites: Effect on clinical, renal, humoral and hemodynamic parameters. Hepatology 1995; 21:986994.MEDLINE
  • 18
    Wong F, Sniderman K, Liu P, Allidina Y, Sherman M, Blendis L. Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Ann Intern Med 1995; 122:816822.MEDLINE
  • 19
    Ochs A, Rössle M, Haag K, Hauentsein KH, Deibert P, Siegerstetter V, Huonker M, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995; 332:11921197.MEDLINE
  • 20
    Somberg KA. Transjugular intrahepatic portosystemic shunt in the treatment of refractory ascites and hepatorenal syndrome. In: EpsteinM, ed. The Kidney in Liver Disease, 4th ed. Philadelphia: Hanley & Belfus, 1996:507516.
  • 21
    Wong F. Blendis L. Transjugular intrahepatic portosystemic shunt for refractory ascites: tipping the sodium balace. Hepatology 1995; 22:358364.MEDLINE
  • 22
    Crenshaw WB, Gordon FD, McEniff NJ, Perry LJ, Hartnell G, Anastopoulos H, Jenkins RL, et al. Severe ascites: efficacy of the transjugular intrahepatic portosystemic shunt in treatment. Radiology 1996; 200:185192.MEDLINE
  • 23
    Lake JR, Ring E, LaBerge J, Gordon R, Roberts J, Ascher N. Transjugular intrahepatic portocaval stent shunt in patients with renal insufficiency. Transplant Proc 1993; 25:17661767.MEDLINE
  • 24
    Alam I, Bass NM, LaBerge JM, Ring EJ, Somberg KA. : Treatment of hepatorenal syndrome with the transjugular intrahepatic portosystemic shunt (TIPS). Gastroenterology 1995; 108:1024A.
  • 25
    Spahr L, Fenyeves D, N'Guyen VV, Roy L, Legault L, Dufresne MP, Pomier-Layrargues G. Improvement of hepatorenal syndrome by transjugular intrahepatic portosystemic shunt. Am J Gastroenterol 1995; 90:11691170.MEDLINE
  • 26
    Lerut J, Goffette P, Laterre PF, Donataccio M, Reynaert MS, Otte JB. Sequential treatment of hepatorenal syndrome and posthepatic cirrhosis by intrahepatic portosystemic shunt (TIPSS) and liver transplantation. Hepatogastroenterology 1995; 42:985987.MEDLINE
  • 27
    Sturgis TM. Hepatorenal syndrome: resolution after transjugular intrahepatic portosystemic shunt. J Clin Gastroenterol 1995; 20:241243.MEDLINE
  • 28
    Follo A, Llovet JM, Navasa M, Planas R, Forns X, Francitorra A, Rimola A, et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 1994; 20:14951501.MEDLINE
  • 29
    Casado M, Bosch J, Garcia-Pagán JC, Bru C, Bañares R, Bandi JC, Escorsell A, et al. Clinical events following transjugular intrahepatic portosystemic shunt placement: correlation with hemodynamic findings. Gastroenterology 1998; 114:110.
  • 30
    Ginès P, Jiménez W, Arroyo V, Navasa M, López C, Titó L, Serra A, et al. Atrial natriuretic factor in cirrhosis with ascites: plasma levels, cardiac release and splanchnic extraction. Hepatology 1988; 8:636642.MEDLINE
  • 31
    Saló J, Fernández-Esparrach G, Ginès P, Ginès A, Guevara M, Sort P, Jiménez W, et al. Urinary endothelin-like immunoreactivity in patients with cirrhosis. J Hepatol 1997; 27:810816.MEDLINE
  • 32
    Heyrovsky A. A new method for the determination of inulin in plasma and urine. Clin Chim Acta 1956; 1:470474.
  • 33
    Brun C. A rapid method for the determination of para-aminohippuric acid and kidney function tests. J Lab Clin 1951; 37:955958.
  • 34
    Schroeder ET, Anderson GH, Smulyan H. Effects of a portacaval or peritoneovenous shunt on renin in the hepatorenal syndrome. Kidney Int 1979; 15:5461.MEDLINE
  • 35
    Ariyan S, Sweeny T, Kerstein MD. The hepatorenal syndrome: recovery after portacaval shunt. Ann Surg 1975; 181:847849.MEDLINE
  • 36
    Papper S. Hepatorenal syndrome. In: EpsteinM, ed. The Kidney in Liver Disease. 2nd ed. New York: Elsevier, 1983:87106.
  • 37
    Ginès A, Escorsell A, Ginès P, Saló J, Jiménez W, Inglada L, Navasa M, et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993; 105:229236.MEDLINE
  • 38
    Blei AT. Hepatic encephalopaty in the age of TIPS. Hepatology 1994; 20:249252.MEDLINE
  • 39
    Sanyal AJ, Freedman AM, Shiffman ML, Purdum PP, Luketic VA, Cheatham AK. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology 1994; 20:4655.MEDLINE
  • 40
    Riggio O, Merli M, Pedretti G, Servi R, Meddi P, Lionette R, Rossi P, et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors. Dig Dis Sci 1996; 41:578584.MEDLINE
  • 41
    Rössle M. The transjugular intrahepatic portosystemic shunt. J Hepatol 1996; 26:224231.
  • 42
    Rector WG. Portal hypertension: a permissive factor only in the development of ascites and variceal bleeding. Liver 1986; 6:221226.MEDLINE
  • 43
    Morali GA, Sniderman KW, Deitel KM, Tobe S, Witt-Sullivan H, Simon M, Heathcote J, et al. Is sinusoidal portal hypertension a necessary factor for the development of hepatic ascites? J Hepatol 1992; 16:249250.MEDLINE
  • 44
    Henriksen J, Møller S. Hemodynamics, distribution of blood volume, and kinetics of vasoactive substances in cirrhosis. In: EpsteinM, ed. The Kidney in Liver Disease. Philadelphia: Hanley & Belfus, 1996:241258.
  • 45
    Ginès P, Arroyo V, Rodès J. Disorders of renal function in cirrhosis: Pathophysiology and clinical aspects. In: ZakimD, BoyerT, eds. Hepatology: A Textbook of Liver Diseases. Philadelphia, Saunders, 1996:650674.
  • 46
    Arroyo V, Ginès P, Jiménez W, Rodés J. Ascites, renal failure, and electrolyte disorders in cirrhosis. Pathogenesis, diagnosis and treatment. In: McIntyreN, BenhamouJP, BircherJ, RizzettoM, RodésJ, eds. Oxford: Oxford University Press, 1991:427471.
  • 47
    Guevara M, Ginès P, Fernàndez-Esparrach G, Sort P, Salmerón JM, Jiménez W, Arroyo V, et al. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology 1998; 27:3541.MEDLINE
  • 48
    Lang F, Tschernko E, Schulze E, Ouml;ttl I, Ritter M, Völkl H, Hallbrucker C, et al. Hepatorenal reflex regulating kidney function. Hepatology 1991; 14:590598.MEDLINE
  • 49
    Safirstein R, Levitt MF. A hepatorenal depressor reflex: a possible clue to the pathogenesis of the hepatorenal syndrome. Hepatology 1991; 14:734735.MEDLINE
  • 50
    Solıacute;s-Herruzo JA, Duran A, Favela V, Castellano G, Madrid JL, Muñoz-Yagüe MT, Morillas JD, et al. Effects of lumbar sympathetic block on kidney function in cirrhotic patients with hepatorenal syndrome. J Hepatol 1987; 5:167173.MEDLINE